The present invention is related to a dental composition comprising: (a) at least one polymerizable monomer having at least one ethylenically unsaturated group; (b) a radical initiator system comprising (i) a photosensitizer having an absorption maximum ranging from 400 nm to 800 nm; (ii) a coinitiator; and (iii) a compound of the following formula (1):

##STR00001## wherein R.sup.1 and R.sup.2, which may be the same or different, independently represent a hydrogen atom, a C.sub.1-6 alkyl group, or a C.sub.1-6 alkoxy group; R.sup.3 and R.sup.4, which may be the same or different, independently represent a hydrogen atom, or a C.sub.1-6 alkyl group, or R.sup.3 and R.sup.4 may represent a bond so that the carbon atoms to which R.sup.3 and R.sup.4 are bonded are linked by a double bond; R.sup.5 and R.sup.6, which may be the same or different, independently represent a hydrogen atom, or a C.sub.1-6 alkyl group, or R.sup.5 and R.sup.6 may represent a bond so that the carbon atoms to which R.sup.5 and R.sup.6 are bonded are linked by a double bond; L represents a single bond or a group —CRH—, wherein R may be a hydrogen atom, a C.sub.1-6 alkyl group, or a C.sub.1-6 alkoxy group; n and m, independently are integers of 1 to 6.

The present invention is related to a dental composition comprising: (a) at least one polymerizable monomer having at least one ethylenically unsaturated group; (b) a radical initiator system comprising (i) a photosensitizer having an absorption maximum ranging from 400 nm to 800 nm; (ii) a coinitiator; and (iii) a compound of the following formula (1):

##STR00001## wherein R.sup.1 and R.sup.2, which may be the same or different, independently represent a hydrogen atom, a C.sub.1-6 alkyl group, or a C.sub.1-6 alkoxy group; R.sup.3 and R.sup.4, which may be the same or different, independently represent a hydrogen atom, or a C.sub.1-6 alkyl group, or R.sup.3 and R.sup.4 may represent a bond so that the carbon atoms to which R.sup.3 and R.sup.4 are bonded are linked by a double bond; R.sup.5 and R.sup.6, which may be the same or different, independently represent a hydrogen atom, or a C.sub.1-6 alkyl group, or R.sup.5 and R.sup.6 may represent a bond so that the carbon atoms to which R.sup.5 and R.sup.6 are bonded are linked by a double bond; L represents a single bond or a group —CRH—, wherein R may be a hydrogen atom, a C.sub.1-6 alkyl group, or a C.sub.1-6 alkoxy group; n and m, independently are integers of 1 to 6.

Provided herein are dental compositions and methods for use in dental cementation applications.

Provided herein are dental compositions and methods for use in dental cementation applications.

The invention relates to a curable composition for dental retraction comprising a resin matrix comprising at least one polyorganosiloxane with at least two olefinically unsaturated groups as component A1, at least one organohydrogenpolysiloxane as component A2, optionally at least one vinyl functional QM silicone component as component A3, at least one alkylsiloxane having at least one carbinol, silanol, or alkoxy moiety as component B, optionally surfactant(s) as component E, optionally additive(s) as component F, a filler system comprising filler(s) as component D, a catalyst system comprising addition cure catalyst component C-A suitable to cure components A1 and A2, condensation cure catalyst component C-B suitable to cure component B, the curable composition being provided as a kit of part comprising a Catalyst Part I and a Base Part II the Catalyst Part I comprising components C-A, C-B, A1, the Base Part II comprising components A2, A1, B, wherein each of components D, E and F and A3, if present, can be present either in the Catalyst Part I or the Base Part II or the Catalyst Part I and the Base Part II, and wherein component B is present in an amount of 6 wt. % or more with respect to the whole composition.

The invention relates to a curable composition for dental retraction comprising a resin matrix comprising at least one polyorganosiloxane with at least two olefinically unsaturated groups as component A1, at least one organohydrogenpolysiloxane as component A2, optionally at least one vinyl functional QM silicone component as component A3, at least one alkylsiloxane having at least one carbinol, silanol, or alkoxy moiety as component B, optionally surfactant(s) as component E, optionally additive(s) as component F, a filler system comprising filler(s) as component D, a catalyst system comprising addition cure catalyst component C-A suitable to cure components A1 and A2, condensation cure catalyst component C-B suitable to cure component B, the curable composition being provided as a kit of part comprising a Catalyst Part I and a Base Part II the Catalyst Part I comprising components C-A, C-B, A1, the Base Part II comprising components A2, A1, B, wherein each of components D, E and F and A3, if present, can be present either in the Catalyst Part I or the Base Part II or the Catalyst Part I and the Base Part II, and wherein component B is present in an amount of 6 wt. % or more with respect to the whole composition.

The invention relates to a curable composition for dental retraction comprising a resin matrix comprising at least one polyorganosiloxane with at least two olefinically unsaturated groups as component A1, at least one organohydrogenpolysiloxane as component A2, optionally at least one vinyl functional QM silicone component as component A3, at least one alkylsiloxane having at least one carbinol, silanol, or alkoxy moiety as component B, optionally surfactant(s) as component E, optionally additive(s) as component F, a filler system comprising filler(s) as component D, a catalyst system comprising addition cure catalyst component C-A suitable to cure components A1 and A2, condensation cure catalyst component C-B suitable to cure component B, the curable composition being provided as a kit of part comprising a Catalyst Part I and a Base Part II the Catalyst Part I comprising components C-A, C-B, A1, the Base Part II comprising components A2, A1, B, wherein each of components D, E and F and A3, if present, can be present either in the Catalyst Part I or the Base Part II or the Catalyst Part I and the Base Part II, and wherein component B is present in an amount of 6 wt. % or more with respect to the whole composition.

A method of using a dental filler is disclosed. The method may include securing a prosthetic to a dental implant, the prosthetic having an access channel therethrough. The method may also include filling a portion of the access channel by inserting a polytetrafluoroethylene dental plug into the access channel and compressing the polytetrafluoroethylene dental plug within the access channel.

A method of using a dental filler is disclosed. The method may include securing a prosthetic to a dental implant, the prosthetic having an access channel therethrough. The method may also include filling a portion of the access channel by inserting a polytetrafluoroethylene dental plug into the access channel and compressing the polytetrafluoroethylene dental plug within the access channel.

A method of using a dental filler is disclosed. The method may include securing a prosthetic to a dental implant, the prosthetic having an access channel therethrough. The method may also include filling a portion of the access channel by inserting a polytetrafluoroethylene dental plug into the access channel and compressing the polytetrafluoroethylene dental plug within the access channel.